Related references
Note: Only part of the references are listed.Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms A NOVEL THERAPEUTIC STRATEGY FOR ANGIOGENESIS
Dawid G. Nowak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
B. Corkery et al.
ANNALS OF ONCOLOGY (2009)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
Capture of Drug Targets from Live Cells Using a Multipurpose Immuno-Chemo-Proteomics Tool
Chaitanya Saxena et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Identifying the proteins to which small-molecule probes and drugs bind in cells
Shao-En Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Bisindolylmaleimides in anti-cancer therapy - more than PKC inhibitors
B. Pajak et al.
ADVANCES IN MEDICAL SCIENCES (2008)
Activity-based protein profiling: From enzyme chemistry
Benjamin F. Cravatt et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis
Pascal Finetti et al.
CANCER RESEARCH (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
An immuno-chemo-proteomics method for drug target deconvolution
Chaitanya Saxena et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra
Ignat V. Shilov et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry
Josef Wissing et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas
Gregory M. Hayes et al.
CANCER RESEARCH (2007)
Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice
Gert-Jan C. M. van den Bemd et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Preclinical and clinical development of novel agents that target the protein kinase C family
Maria Serova et al.
SEMINARS IN ONCOLOGY (2006)
Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma
GM Hayes et al.
CANCER RESEARCH (2006)
Double-stranded RNA-dependent protein kinase (PKR) is downregulated by phorbol ester
Y Zhou et al.
FEBS JOURNAL (2005)
Chemical strategies for activity-based proteomics
AE Speers et al.
CHEMBIOCHEM (2004)
TANDEM: matching proteins with tandem mass spectra
R Craig et al.
BIOINFORMATICS (2004)
Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors
D Brehmer et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
K Godl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Protein kinase Cα negatively regulates cell spreading and motility in MDA-MB-231 human breast cancer cells downstream of epidermal growth factor receptor
ML Gauthier et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer
JM Nussbaum et al.
CANCER LETTERS (2003)
Chemical proteomics and its application to drug discovery
DA Jeffery et al.
CURRENT OPINION IN BIOTECHNOLOGY (2003)
Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome
JM Peng et al.
JOURNAL OF PROTEOME RESEARCH (2003)
Enhanced gene expression in breast cancer cells in vitro and tumors in vivo
HZ Lu et al.
MOLECULAR THERAPY (2002)
Protein kinases - the major drug targets of the twenty-first century?
P Cohen
NATURE REVIEWS DRUG DISCOVERY (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR
SH Kim et al.
ONCOGENE (2000)
Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer
F Révillion et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
